University of Alabama Receives FDA Approval to Produce, Administer and Study Cannabis Extracts

Cannabis tincture.
Cannabis tincture.

The University of Alabama has received approval from the Food and Drug Administration (FDA) to begin cultivating, administering and studying the impact of low-THC (tetrahydrocannabinol), high-CBD (cannabidiol) cannabis extracts on childhood and adult seizure disorders.

In April, Alabama Governor Robert Bentley signed into law Senate Bill 174 which authorizes the University of Alabama’s Department of Neurology to prescribe, produce and distribute low-THC cannabis extracts Рsuch as cannabis oil and tinctures Рto those with seizure disorders. The oil must be primarily CBD, and can contain no more than 3% THC.

Read moreUniversity of Alabama Receives FDA Approval to Produce, Administer and Study Cannabis Extracts